Novartis Foundation Showcases Progress In Leprosy Elimination Programs At 19th International Leprosy Congress

On Friday afternoon, the FDA’s oncology drug advisory committee unanimously voted 16- against the approval of Y-mAbs’ experimental drug for CNS metastases in pediatric...